EXEL - Exelixis, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
12/30/2015
Total Revenue
909,761
853,826
452,477
191,454
37,172
Cost of Revenue
29,752
26,348
15,066
6,552
3,895
Gross Profit
880,009
827,478
437,411
184,902
33,277
Operating Expenses
Research Development
247,233
182,257
112,171
95,967
96,351
Selling General and Administrative
219,450
206,366
159,362
116,145
57,305
Total Operating Expenses
466,683
388,623
271,533
212,112
153,656
Operating Income or Loss
413,326
438,855
165,878
-27,210
-120,379
Interest Expense
-
0
8,679
33,060
48,673
Total Other Income/Expenses Net
1,128
397
-3,505
-14,815
-1,042
Income Before Tax
435,764
452,092
158,577
-70,222
-169,682
Income Tax Expense
-205,772
-237,978
4,350
0
55
Income from Continuing Operations
641,536
690,070
154,227
-70,222
-169,737
Net Income
641,536
690,070
154,227
-70,222
-169,737
Net Income available to common shareholders
641,536
690,070
154,227
-70,222
-169,737
Reported EPS
Basic
-
2.32
0.52
-0.28
-0.81
Diluted
-
2.21
0.49
-0.28
-0.81
Weighted average shares outstanding
Basic
-
297,892
293,588
250,531
209,227
Diluted
-
312,803
312,003
250,531
209,227
EBITDA
-
452,092
167,256
-37,162
-121,009